Health / Resources / Technology

Penn prof Rahul Kohli wins GlaxoSmithKline drug competition

The professor, Rahul Kohli, is developing drugs that aim to prevent bacteria from becoming resistant to antibiotics. As one of the winners, Kohli gets access to GlaxoSmithKline's resources to test and develop his research further.

GlaxoSmithKline held a competition to find fledgling research it might eventually be able to commercialize as one of its own products, like its fruit drink Ribena, shown here. Photo by Iain Crockett for GlaxoSmithKline.

A Penn professor was one of eight winners of a national competition where pharma giant GlaxoSmithKline sought early-stage research that could become new kinds of medicine, according to a release.

The professor, Rahul Kohli, is developing drugs that aim to prevent bacteria from becoming resistant to antibiotics. As one of the winners, Kohli gets access to GlaxoSmithKline’s resources to test and develop his research further. That access, Kohli said, can speed up the chance of his work saving lives.

“[GlaxoSmithKline’s resources are] tremendously valuable to efficiently moving the project from a theoretical academic pursuit into a practical one which can potentially benefit patients,” said Kohli, who teaches at Penn’s medical school.

While GlaxoSmithKline often works with academic researchers to develop potential drugs, it’s the first time it held a competition with an open call for submissions like this, said spokeswoman Melinda Stubbee. Normally, Stubbee said, GlaxoSmithKline scouts researchers or works with those who are familiar with the process and know to reach out to the corporation, which has U.S. headquarters is at the Navy Yard.

GlaxoSmithKline launched the competition to cast a wider net, Stubbee said, and it worked: the competition received 142 submissions from the U.S. and Canada, according to the release. Find a full list of winners here.

The competition is part of the trend of academic research being funded more and more by corporations, GlaxoSmithKline’s Pearl Huang told Newsworks. Huang heads the company’s program to partner with academic institutions. Traditionally, university research has been funded by the federal government.

If the development phase is successful for Kohli or any of his fellow winners, GlaxoSmithKline could offer to commercialize his work.

Companies: GlaxoSmithKline / University of Pennsylvania

Before you go...

Please consider supporting to keep our independent journalism strong. Unlike most business-focused media outlets, we don’t have a paywall. Instead, we count on your personal and organizational support.

3 ways to support our work:
  • Contribute to the Journalism Fund. Charitable giving ensures our information remains free and accessible for residents to discover workforce programs and entrepreneurship pathways. This includes philanthropic grants and individual tax-deductible donations from readers like you.
  • Use our Preferred Partners. Our directory of vetted providers offers high-quality recommendations for services our readers need, and each referral supports our journalism.
  • Use our services. If you need entrepreneurs and tech leaders to buy your services, are seeking technologists to hire or want more professionals to know about your ecosystem, has the biggest and most engaged audience in the mid-Atlantic. We help companies tell their stories and answer big questions to meet and serve our community.
The journalism fund Preferred partners Our services

Join our growing Slack community

Join 5,000 tech professionals and entrepreneurs in our community Slack today!


Here’s how the global tech outage impacted many of the vital systems across the mid-Atlantic region

Why Benefits Data Trust fell apart despite millions from philanthropy and government contracts

Ready to start marketing your startup? 3 crucial questions all founders should ask

From Big Tech to a big bank, this leader puts innovation at the forefront of her entire career

Technically Media